2 September 2026
Executive Summary
A European Union regulatory change taking effect tomorrow, 3 September, provides an unusually clear example of how market access can disappear even when the underlying product itself has not suddenly changed.
Brazil will no longer be authorised for entry into the EU of several categories of animals and products of animal origin affected by the bloc’s new antimicrobial requirements after failing to provide the required evidence and guarantees of compliance.
The relevant EU regulation removes Brazil’s authorisation for categories including bovine, equine, poultry, aquaculture, honey and casings, with the new arrangements applying from 3 September 2026.
The requirements concern restrictions on the use of certain antimicrobial medicines, including rules intended to prevent practices such as the use of antimicrobials for growth promotion and protect medicines considered important for treating human disease.
The commercial lesson is particularly useful:
A supplier does not necessarily have to fail a product test for trade to stop. It can fail to demonstrate that its production and assurance system meets the destination market’s rules.
UK Impact
This story has an especially important UK dimension.
Great Britain is not introducing equivalent new restrictions on 3 September.
DEFRA/APHA is conducting its own independent assessment of Brazil’s antimicrobial assurance arrangements.
The current official position is that products of animal origin from Brazil may continue to be imported into Great Britain after 3 September, provided they satisfy existing GB import requirements.
Northern Ireland is different because relevant goods moving into Northern Ireland must satisfy applicable EU import rules.
That creates potential complexity for businesses operating across GB, Northern Ireland and EU markets.
A product may therefore be:
lawfully imported into Great Britain
but unsuitable for onward movement into an EU-regulated supply chain.
That distinction matters enormously for:
- Food manufacturers.
- Wholesalers.
- Retailers.
- Restaurants.
- Importers.
- Distribution businesses.
- Exporters.
A British company using Brazilian-origin ingredients may need to consider where the finished product will ultimately be sold.
UK port-health guidance specifically warns that products imported from Brazil and subsequently exported to the EU may face additional certification requirements or become ineligible for EU export depending upon the product and ingredients involved.
Global Impact
This is a good example of regulation becoming a supply-chain barrier rather than merely a compliance obligation.
The crucial issue is increasingly traceability and evidence.
Regulators may want businesses to demonstrate not simply that the final product satisfies a rule, but that practices throughout the production chain satisfy it.
Similar approaches are appearing across:
- Deforestation regulation.
- Carbon reporting.
- Forced-labour controls.
- Sanctions.
- Critical minerals.
- Food safety.
- ESG due diligence.
That changes the nature of supplier verification.
A certificate at the end of the process may no longer be sufficient.
Businesses increasingly need visibility much further upstream.
Our View
Companies trading internationally should maintain a destination-market compliance map rather than assuming one product can move everywhere once imported.
Businesses should ask:
- Which jurisdictions can this product legally enter?
- Does the rule apply to the final product or its ingredients?
- Can origin be traced through the entire production process?
- Do suppliers provide sufficient evidence?
- Could the evidence be independently verified?
- Are alternative suppliers already approved?
- Could inventory become stranded after a regulatory change?
- Can stock imported into one jurisdiction be moved into another?
- Are ERP systems capable of separating compliant and non-compliant batches?
- Could finished products lose export eligibility because of one ingredient?
- Do contracts allocate regulatory-change risk?
- Who bears the loss if market access disappears?
There is an important distinction between product quality and market eligibility.
A product can remain commercially usable somewhere in the world while becoming impossible to sell into one particular jurisdiction because its compliance framework no longer satisfies that market.
Regulatory resilience therefore requires knowing not merely what you own — but where you are still legally able to sell it.
Risk Indicator: ELEVATED – REGULATORY, SUPPLY CHAIN & TRADE
Does This Risk Affect Your Business?
Invictus Risk Solutions helps businesses find practical solutions to insurance, risk and commercial challenges.
From individual businesses to major international organisations, risk is our business.
TALK TO INVICTUS →Disclaimer
The information contained within these Market Alerts is provided for general market awareness and informational purposes only. It does not constitute financial, legal, investment, regulatory or insurance advice. Whilst every effort has been made to ensure accuracy at the time of publication using multiple reputable and independently verified sources, geopolitical events, legislation, regulation and market conditions may change rapidly. Readers should obtain appropriate professional advice before acting upon any information contained herein.
Invictus Risk Solutions LLP – Helping organisations stay ahead of emerging risks through informed insight and independent analysis.